
Bravin Pharmaceuticals Private Limited
About Bravin Pharmaceuticals Private Limited
Data last updated:
Bravin Pharmaceuticals Private Limited was a private limited company based in Patna, Bihar, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 14 December 2012.
The company was registered with the Registrar of Companies (ROC), Patna, under CIN U51397BR2012PTC019646.
The company had an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Komal Tripti and Vindvasani Devi.
Its last annual general meeting (AGM) was held on 30 September 2015, and its latest financial statements are for the year ended 31 March 2015. The registered office was at A/10 Vijay Nagar Kankarbagh, Patna, Bihar, India – 800020.
Company details
Contact details
Bravin Pharmaceuticals Private Limited's registered office is in Patna, Bihar.
- Registered AddressA/10 Vijay Nagar Kankarbagh, Patna, Bihar, India – 800020
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Bravin Pharmaceuticals Private Limited
FY 2015 filings availableFinancial Statement Summary
| Metrics | FY 2014-15 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2014-15 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Bravin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bravin Pharmaceuticals Private Limited
Bravin Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Komal Tripti | Director | 14 Dec 2012 | 13 Years 10 Months | As last reported |
| Vindvasani Devi | Director | 28 Oct 2014 | 12 Years 0 Months | As last reported |
Legal cases
No court or tribunal cases involving Bravin Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bravin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Bravin Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Bravin Pharmaceuticals Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Vindvasani Devi ceased to be Additional Director on 30 Sep 2015.
Frequently asked questions
Bravin Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Bravin Pharmaceuticals was a private limited company based in Patna, Bihar, India. The company worked in wholesale, within the trading industry. It was incorporated on 14 December 2012 and is registered under CIN U51397BR2012PTC019646. The company has been struck off by the Registrar of Companies and is no longer operational.
Bravin Pharmaceuticals had 2 directors:
- Komal Tripti - Director
- Vindvasani Devi - Director
The CIN (Corporate Identification Number) of Bravin Pharmaceuticals is U51397BR2012PTC019646. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Bravin Pharmaceuticals is at A10 Vijay Nagar Kankarbagh, Patna, Bihar, India – 800020.
Bravin Pharmaceuticals was incorporated on 14 December 2012. It is registered with the Registrar of Companies, Patna.
The latest financial statements of Bravin Pharmaceuticals on record with the MCA are for the year ended 31 March 2015. Its last annual general meeting was held on 30 September 2015. Year-wise statements from 2015 are in the company report.
Bravin Pharmaceuticals operated in the trading industry, in the wholesale segment. It worked in this industry before it was struck off.
Vindvasani Devi ceased to be Additional Director on 30 Sep 2015. Rajeev Ranjan Tiwari ceased to be Director on 28 Oct 2014. Vindvasani Devi was appointed as Director on 28 Oct 2014. Bravin Pharmaceuticals has 4 board changes on record in total.
The compliance status of Bravin Pharmaceuticals is active non-compliant as of 26 September 2026.

